ZENCORE NEWS & EVENTS

News & Events News & Events

Zencore News
Breaking News | Zencore Biologics Successfully Obtains the “Drug Production License,” Reaching an Important Milestone in Its Growth
2025-01-16

Breaking News | Zencore Biologics Successfully Obtains the “Drug Production License,” Reaching an Important Milestone in Its Growth

View details
Congratulations | Novotel Biotech Approved to Conduct Phase I Clinical Trial of Recombinant Human Hyaluronidase Injection
2024-12-31

Congratulations | Novotel Biotech Approved to Conduct Phase I Clinical Trial of Recombinant Human Hyaluronidase Injection

View details
Zencore's "Hyaluronidase" Pharmaceutical Excipient Registered with NMPA
2024-12-22

Zencore's "Hyaluronidase" Pharmaceutical Excipient Registered with NMPA

View details
Congratulations to Zencore Biologics for being awarded the title of "Shanghai Key Service Unicorn Enterprise"
2024-04-28

Congratulations to Zencore Biologics for being awarded the title of "Shanghai Key Service Unicorn Enterprise"

View details
Congratulations to D2M Biotherapeutics on the NMPA Approval for the First Proprietary Pipeline Product DM919
2024-04-12

Congratulations to D2M Biotherapeutics on the NMPA Approval for the First Proprietary Pipeline Product DM919

View details
Strategic Collaboration | Zencore Biologics Signed a Strategic Cooperation Agreement with Apeloa Pharmaceutical
2024-03-06

Strategic Collaboration | Zencore Biologics Signed a Strategic Cooperation Agreement with Apeloa Pharmaceutical

View details
Warmly welcome the delegation from Shanghai Municipal Commission of Economy and Informatization to visit Zencore Biologics
2024-02-02

Warmly welcome the delegation from Shanghai Municipal Commission of Economy and Informatization to visit Zencore Biologics

View details
Amazing Recap: 2024 Zencore Biologics Annual Gala and Awards Ceremony Successfully Concludes
2024-02-02

Amazing Recap: 2024 Zencore Biologics Annual Gala and Awards Ceremony Successfully Concludes

View details
Congratulations to D2M Biotherapeutics on the IND Approval for the First Proprietary Pipeline Product DM919
2023-12-29

Congratulations to D2M Biotherapeutics on the IND Approval for the First Proprietary Pipeline Product DM919

View details